Most Americans Unaware of Excessive Weight as a Risk for Some Cancers

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 10
Volume 11
Issue 10

WASHINGTON-Most Americans worry about developing cancer and being overweight, but few of them recognize that excessive pounds are a risk factor for some common cancers, according to a new survey commissioned by the American Institute for Cancer Research (AICR). Of those polled, 61% said they were either very or somewhat concerned about receiving a diagnosis of cancer. Yet when asked to name major risk factors for cancer other than smoking, only 6% listed overweight or obesity.

WASHINGTON—Most Americans worry about developing cancer and being overweight, but few of them recognize that excessive pounds are a risk factor for some common cancers, according to a new survey commissioned by the American Institute for Cancer Research (AICR). Of those polled, 61% said they were either very or somewhat concerned about receiving a diagnosis of cancer. Yet when asked to name major risk factors for cancer other than smoking, only 6% listed overweight or obesity.

A recent review of the scientific literature by AICR found that excessive weight increased the risk of six types of malignancies—postmenopausal breast, colon, endometrial, esophageal, prostate, and kidney—by 25% to 33%.

In the survey, conducted by the polling firm Harris Interactive, only 14% said they were not concerned at all about getting cancer and 24% said they were not very concerned. A significantly greater percentage of Americans earning less than $15,000 expressed concern about developing the disease than those earning higher incomes—35% vs 20%. And 73% of blacks said they were very or somewhat concerned vs 60% of whites. Women are more concerned than men: While 41% of the men said they were not worried about cancer, only 34% of the women expressed no concern.

When asked about cancer risk factors other than smoking, survey respondents mentioned certain chemicals (22%), overexposure to the sun (18%), consuming a high-fat diet (18%), heavy alcohol use (7%), and excessive weight (6%).

Recent Videos
Future findings from a translational analysis of the OVATION-2 trial may corroborate prior clinical data with IMNN-001 in advanced ovarian cancer.
The dual high-affinity binding observed with ISB 2001 may avoid resistance mechanisms reported with other BCMA-targeted therapies.
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.
2 experts in this video
Related Content